Humana Inc. revised earnings guidance for the year ending December 31, 2024. For the year, the company expects GAAP EPS to be approximately $13.93 against previous guidance of approximately $14.87.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
335.6 USD | +0.27% | +4.70% | -26.70% |
May. 02 | Cigna sees strong annual profit on lower costs, pharmacy benefit strength | RE |
Apr. 26 | Deutsche Bank Adjusts Price Target on Humana to $341 From $355 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.70% | 40.44B | |
+14.34% | 125B | |
+16.34% | 98.97B | |
+4.82% | 41.51B | |
-1.86% | 20.78B | |
-25.95% | 2.62B | |
-20.67% | 1.31B | |
-13.87% | 407M |
- Stock Market
- Equities
- HUM Stock
- News Humana Inc.
- Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024